About Estuary Biotherapeutics
Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
San Francisco, United States
Team Size
11-50
Tracked Since
Oct 17, 2026
Web & Domain Identity
Official Website
estuarybio.com
Domain Registered Date
Dec 26, 2022
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $103,000,000 · Series-A
Backed by RA Capital Management, 4BIO Capital
- Milestone
Website domain registered
estuarybio.com
Investors & Backers
4BIO Capital
Biogen New Ventures
Deep Track Capital
GV
National Kidney Foundation
Pivotal bioVenture Partners
RA Capital Management
UPMC Enterprises
Funding History
Series-A equity
· Oct 16, 2026
Round backers: RA Capital Management, 4BIO Capital, Biogen New Ventures, Deep Track Capital, GV, National Kidney Foundation, Pivotal bioVenture Partners, UPMC Enterprises
$103,000,000 estuarybio.com
Founders & Leadership
Wayne Sackett
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026